Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2023-05-02
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia
NCT02675270
Exploring to Remediate Behavioral Disturbances of Spatial Cognition
NCT05944601
Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy
NCT01384344
Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
NCT01049555
Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project
NCT01798199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Video 360
Patients will watch spherical videos displaying everyday actions towards objects; an audio is embedded describing the action and the object represented (i.e. "I'm cutting the potatoes").
Video 360
Patients will undergo 12 sessions, 3 per weeks, 4 weeks
Standard video
Patients will watch standard videos displaying everyday actions towards objects; an audio is embedded describing the action and the object represented (i.e. "I'm cutting the potatoes")
Standard videos
Patients will undergo 12 sessions, 3 per weeks, 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video 360
Patients will undergo 12 sessions, 3 per weeks, 4 weeks
Standard videos
Patients will undergo 12 sessions, 3 per weeks, 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to have already received rehabilitation treatment in the acute phase
* noun naming below cut-off
* verbs naming below cut- off
Exclusion Criteria
* epilepsy
* balance disorders
* neglect
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Poliambulanza
UNKNOWN
Catholic University of the Sacred Heart
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Repetto
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Repetto, Prof
Role: PRINCIPAL_INVESTIGATOR
Catholic University of the Sacred Heart
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Poliambulanza
Brescia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alessandra Maietti, Msc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.